Christopher Benecchi

Corporate Officer/Principal bei SAGE THERAPEUTICS, INC.

Vermögen: 80 529 $ am 30.04.2024

Health Technology

Consumer Services

Finance

Aktive Positionen von Christopher Benecchi

Unternehmen	Position	Beginn	Ende
SAGE THERAPEUTICS, INC.	Corporate Officer/Principal	21.09.2021	-

Unternehmen	Position	Beginn	Ende
ALEXION PHARMACEUTICALS, INC.	Corporate Officer/Principal	01.08.2019	01.09.2021
UCB, Inc. UCB, Inc. Financial ConglomeratesFinance Part of UCB SA, UCB, Inc. provides financial services. The company is based in Smyrna, GA. The CEO of the company is Duane Barnes.	Corporate Officer/Principal	01.08.2011	01.08.2019

Duke University	Masters Business Admin
Colby College	Undergraduate Degree

International

Vereinigte Staaten

Operativ

Corporate Officer/Principal	3
Masters Business Admin	1
Undergraduate Degree	1

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
SAGE THERAPEUTICS, INC.	Health Technology

Private Unternehmen	2
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA.	Health Technology
UCB, Inc. UCB, Inc. Financial ConglomeratesFinance Part of UCB SA, UCB, Inc. provides financial services. The company is based in Smyrna, GA. The CEO of the company is Duane Barnes.	Finance

Private Unternehmen

Health Technology

Finance